Etiology and Key Pathogenetic Mechanisms
The development of drug-induced hepatitis is directly related to the entry of foreign chemical compounds—xenobiotics—into the body. These include medicinal agents with proven hepatotoxic effects, as well as various chemical substances encountered in daily life or the workplace. The liver, serving as the body's main biochemical laboratory, is responsible for their metabolism and detoxification. This exact function creates an extremely high risk of parenchymal liver damage.
In pathological anatomy, three fundamental mechanisms of hepatocyte injury are distinguished in drug-induced hepatitis:
- Direct Toxic Effect. In this case, the chemical substance or toxin has the capacity to directly destroy liver cells without prior biochemical transformations. A classic example of such severe direct injury is poisoning with Amanita phalloides (death cap) toxin, which causes rapid hepatocyte death.
- Metabolite Toxicity (Xenobiotic Conversion). The parent drug may not possess marked toxicity; however, during its biotransformation and metabolism within the liver, highly active and aggressive metabolites are formed. It is these intermediate products that inflict cellular damage. Typical examples of drugs damaging the liver via this pathway include tetracycline antibiotics and salicylates.
- Immune Mechanisms (Hapten Mechanism). This is a more complex pathway in which the drug itself or its breakdown product acts as a hapten—an incomplete antigen. The hapten firmly binds to normal structural proteins of the hepatocyte. As a result of this binding, the liver cell's own proteins are transformed into immunogens. The immune system recognizes them as foreign elements and mounts a powerful immune attack, destroying the body's own tissues. A characteristic example of a drug triggering the hapten mechanism is the inhalation anesthetic halothane.
Clinical and Morphological Features and Course Variants
The clinical presentation and morphological changes in liver tissue during drug-induced injury largely depend on the nature of the pathological process. Two main variants are distinguished:
- Acute Course. This variant is distinguished by rapid progression and may manifest initially with features of liver failure. Histological examination reveals severe destructive changes: submassive or massive hepatocyte necrosis. Additionally, the morphological picture is supplemented by signs of pronounced intrahepatic cholestasis (bile stasis) and an intense inflammatory process in the organ parenchyma.
- Chronic Course. In contrast to the acute form, chronic drug-induced hepatitis is characterized by an asymptomatic course in its initial stages. The patient may remain unaware of the problem for a long time. However, the pathological process progresses steadily, ultimately leading to a gradual, time-prolonged development of liver failure.
Principles of Differential Diagnosis
Establishing an accurate diagnosis when drug-induced hepatitis is suspected represents a serious clinical challenge. The main problem is that chronic drug-induced hepatitis is completely indistinguishable from chronic viral hepatitis. This identity is observed both at the level of clinical symptoms and during detailed microscopic examination of liver tissue.
To perform proper differentiation, clinicians must rely on the following criteria:
- Serological Markers. Viral etiology can only be excluded or confirmed by laboratory screening for specific serological markers of viral infection.
- Evaluation of Outcome After Drug Withdrawal. A crucial diagnostic and therapeutic step is the discontinuation of the suspected hepatotoxic drug. If the inflammation was indeed caused by the medication, the pathological process resolves after stopping its intake.